Autism spectrum disorder (ASD) is a neurological disorder triggered by various factors through complex mechanisms. Research has been done to elucidate the potential etiologic mechanisms in ASD, but no single cause has been confirmed. The involvement of oxidative stress is correlated with ASD and possibly affects mitochondrial function. This study aimed to elucidate the link between mitochondrial dysregulation and idiopathic ASD by focusing on mitochondrial respiratory capacity and membrane potential. Our findings showed that mitochondrial function in the energy metabolism pathway was significantly dysregulated in a lymphoblastoid cell line (LCL) derived from an autistic child (ALCL). Respiratory capacities of oxidative phosphorylation (OXPHOS), electron transfer of the Complex I and Complex II linked pathways, membrane potential, and Complex IV activity of the ALCL were analyzed and compared with control cell lines derived from a developmentally normal non-autistic sibling (NALCL). All experiments were performed using high-resolution respirometry. Respiratory capacities of OXPHOS, electron transfer of the Complex I- and Complex II-linked pathways, and Complex IV activity of the ALCL were significantly higher compared to healthy controls. Mitochondrial membrane potential was also significantly higher, measured in the Complex II-linked pathway during LEAK respiration and OXPHOS. These results indicate the abnormalities in mitochondrial respiratory control linking mitochondrial function with autism. Correlating mitochondrial dysfunction and autism is important for a better understanding of ASD pathogenesis in order to produce effective interventions.
1 December 2020 in Oxidative Medicine and Cellular Longevity
Autism has been associated with a low antioxidant defense mechanism, while honey has been known for decades for its antioxidant and healing properties. Determination of stingless bee honey (KH) effects on antioxidant enzyme activities and oxidative damage in Autism Lymphoblastoid Cell Line (ALCL) was performed. ALCL and its normal sibling pair (NALCL) were cultured in RPMI-1640 medium at 37°C and 5% CO2. ALCL was treated with 400 μg/mL KH (24 h), and oxidative stress marker, malondialdehyde (MDA), and antioxidant enzyme activities (catalase (CAT), glutathione peroxidase (GPx), and superoxide dismutase (SOD)) were measured via enzyme-linked immunosorbent assay (ELISA), while deoxyribonucleic acid (DNA) damage was determined via comet assay. Low SOD activity ( ) and high MDA level ( ) were observed in ALCL compared to NALCL. Higher grade (Grades 2 and 3) of DNA damage was highly observed ( ) in ALCL compared to NALCL, whereas lower grade (Grades 0 and 1) DNA damage was highly detected ( ) in NALCL compared to ALCL. KH treatment caused a significant increase in SOD and GPx activities ( ) in ALCL compared to untreated ALCL. Correspondingly, KH treatment reduced the Grade 2 DNA damage ( ) in ALCL compared to untreated ALCL. CAT activity showed no significant difference between all three groups, while the MDA level showed no significant difference between treated and untreated ALCL. In conclusion, KH treatment significantly reduced the oxidative stress in ALCL by increasing the SOD and GPx antioxidant enzyme activities, while reducing the DNA damage.
About Me
Hazirah Hassan is a PhD candidate in the Department of Biochemistry, Faculty of Medicine, Universiti Kebangsaan Malaysia. She received her B.Sc.(Biotechnology) majoring in Genetics and Biochemistry in 2014 and M.Biotech(Biomedical) in 2016 from the University of Adelaide, Australia. Her current research interest is mainly on mitochondria dysfunction in Autism. She received the Faculty of Sciences Outstanding Academic Achievement Award for three consecutive years; 2014, 2015 and 2016. She also received the Summer Research Scholarships from the University of Adelaide. She received the Best Poster Presenter award in an international conference, ICADD 2018.
Hazirah Hassan is a PhD candidate in the Department of Biochemistry, Faculty of Medicine, Universiti Kebangsaan Malaysia. She received her B.Sc.(Biotechnology) majoring in Genetics and Biochemistry in 2014 and M.Biotech(Biomedical) in 2016 from the University of Adelaide, Australia. Her current research interest is mainly on mitochondria dysfunction in Autism. She received the Faculty of Sciences Outstanding Academic Achievement Award for three consecutive years; 2014, 2015 and 2016. She also received the Summer Research Scholarships from the University of Adelaide. She received the Best Poster Presenter award in an international conference, ICADD 2018.